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Abstract
Introduction: The Activity-Regulated Cytoskeleton-associated (ARC) gene
encodes a protein that is critical for the consolidation of synaptic plasticity and
long-term memory formation. Given ARC’s key role in synaptic plasticity, we
hypothesized that genetic variations in ARC may contribute to interindividual
variability in human cognitive abilities or to attention-deficit hyperactivity dis-
order (ADHD) susceptibility, where cognitive impairment often accompanies
the disorder. Methods: We tested whether ARC variants are associated with six
measures of cognitive functioning in 670 healthy subjects in the Norwegian
Cognitive NeuroGenetics (NCNG) by extracting data from its Genome-Wide
Association Study (GWAS). In addition, the Swedish Betula sample of 1800
healthy subjects who underwent similar cognitive testing was also tested for
association with 19 tag SNPs. Results: No ARC variants show association at the
study-wide level, but several markers show a trend toward association with
human cognitive functions. We also tested for association between ARC SNPs
and ADHD in a Norwegian sample of cases and controls, but found no signifi-
cant associations. Conclusion: This study suggests that common genetic vari-
ants located in ARC do not account for variance in human cognitive abilities,
though small effects cannot be ruled out.
ª 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.
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Introduction
The immediate early gene, ARC/ARG3.1 (activity-regulated
cytoskeleton-associated protein/activity-regulated gene 3.1;
here denoted as “ARC” for the gene and “Arc” for the
mRNA and protein), controls diverse forms of experience-
dependent synaptic plasticity and memory formation in the
mammalian brain (Plath et al. 2006; Bramham et al. 2010;
Korb and Finkbeiner 2011; Shepherd and Bear 2011). ARC
is expressed predominantly in excitatory, glutamatergic
projection neurons suggesting late evolutionary emergence
and functional specialization (Campillos et al. 2006; Vaz-
darjanova et al. 2006; Mattaliano et al. 2007). Following
bursts of synaptic activity, Arc mRNA is rapidly induced
and transported to dendritic processes for local storage,
translation, or decay. Synthesis of Arc is required for long-
term potentiation (LTP) and long-term depression (LTD),
the major cellular mechanisms for synaptic strengthening
and weakening, respectively (Chowdhury et al. 2006; Plath
et al. 2006; Rial Verde et al. 2006; Shepherd et al. 2006;
Messaoudi et al. 2007; Panja et al. 2014). Recent studies
show that the Arc protein self-oligomerizes, contains two
biochemically distinct domains that flank a disordered
region, and originated from the Ty3/Gypsy retrotransposon
family (Myrum et al. 2015; Zhang et al. 2015).
Dysregulation of excitatory synaptic transmission and
plasticity is increasingly implicated in the major psychi-
atric disorders, including bipolar disorder (BP),
schizophrenia (SCZ), major depressive disorder (MDD),
attention-deficit hyperactivity disorder (ADHD), and
autism spectrum disorders (ASD) (Toro et al. 2010; Auer-
bach et al. 2011; Grant 2012; Gkogkas et al. 2013; Nithi-
anantharajah et al. 2013; Ripke et al. 2013; The Network
and Pathway Analysis Subgroup of the Psyciatric Geno-
mics Consortium 2015). Synaptic dysfunction may there-
fore play a causal role in cognitive impairments, such as in
inhibitory control and other aspects of executive function,
that are shared across all of the major neuropsychiatric
disorders (Kahn and Keefe 2013). Numerous genetic risk
factors are implicated in psychiatric disorder susceptibility
(Sullivan et al. 2012). SCZ and BP heritability is estimated
to be as high as 70%, whereas ADHD heritability is esti-
mated at 79% (Lichtenstein et al. 2009, 2010). For SCZ,
common genetic variants identified by Genome-Wide
Association Studies (GWAS) currently account for up to
18% of this heritability (Visscher et al. 2012; Ripke et al.
2014), but the heritability explained is lower for other psy-
chiatric traits. Studies looking at the overall effect of com-
mon variants (present in more than 1% of the
population) have shown that common variants could
actually explain 40% of the heritability (Lee et al. 2012),
but we are lacking either the sample size or the statistical
tools to identify these common variants of small effect.
Thus, many common variants of small effect in psychiatric
disorders remain undetected. One approach to increase
the power to identify these variants is to look at additional
phenotypes which are correlated and relevant to these psy-
chiatric traits, such as cognitive abilities (Fernandes et al.
2013; McIntosh et al. 2013; Lencz et al. 2014). As a func-
tionally versatile regulator of plasticity and memory for-
mation, the ARC gene, mRNA, and protein are all tightly
regulated (Bramham et al. 2010). Dysregulation of Arc is
implicated in Angelman syndrome and pathogenesis of
Alzheimer’s disease (Greer et al. 2010; Wu et al. 2011).
We hypothesized that genetic variations in ARC also
could contribute to the range of human cognitive abilities
and impairments in cognition. Previously, postsynaptic
proteins at glutamatergic synapses associated with Arc and
N-methyl-D-aspartate receptor complexes have been
shown to be enriched in SCZ-associated loci containing
copy number variants (CNVs), rare coding variants, and
small de novo mutants (Kirov et al. 2012; Fromer et al.
2014; Purcell et al. 2014) Here, we carried out a compre-
hensive association analysis of ARC genetic variants to
determine whether ARC variation plays a role in general
cognition. First, we tested genetic variants in ARC for their
association with cognitive abilities (word comprehension,
visuospatial ability, intellectual function, verbal learning,
verbal recall, and response inhibition) in two samples with
cognitive phenotyping: the Norwegian Cognitive NeuroGe-
netics sample (NCNG) (Espeseth et al. 2012) and the
Betula sample (Nilsson et al. 1997, 2004). Furthermore, we
checked for association between ARC SNPs and a Norwe-
gian ADHD sample (Jacobsen et al. 2013) since ADHD
patients present with deficits in cognitive abilities, particu-
larly in executive function (Pennington and Ozonoff 1996).
Materials and Methods
The study utilized three independent datasets, which are
described here. A summary of these cohorts are summa-
rized in Table 1.
NCNG
The NCNG (Norwegian Cognitive NeuroGenetics) sample
consists of 670 healthy individuals from whom genetic
Table 1. Summary of cohorts.
Cohort Sample size Mean Age  SD
NCNG 645 47.6  18.26
Betula 1742 62.3  13.3
Norwegian ADHD 661 cases
697 controls
33.95  10.25
29.69  6.52
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and cognitive data were collected. Participants aged 20–80
were recruited through advertisements in local newspa-
pers in the Oslo and Bergen areas. Candidates with past
or present neurological or psychiatric diseases or a history
of substance abuse, learning deficits, or depression were
excluded. Participants were required to be native speakers
of Norwegian and to have completed basic education.
Those scoring more than one standard deviation (SD)
below their age norm on tests of intelligence or memory
were excluded. All participants gave their informed con-
sent for participation, which included donation of a
blood sample, DNA extraction and genotyping, and
storage of the remaining blood sample in a biobank. All
participants read an information sheet and signed a state-
ment of informed consent approved by the regional com-
mittee for Medical and Health Research Ethics (Southeast
Norway; Project ID: S-03116).
The cognitive tests analyzed here (summarized in
Table 2) were the California Verbal Learning Test II
(CVLT II) (Delis et al. 2000), the Color-Word Interfer-
ence Test (CWIT) which is part of the Delis-Kaplan
Executive Function System (DKEFS) (Delis et al. 2001),
and the Vocabulary and Matrix Reasoning subtests from
Wechsler Abbreviated Scale of Intelligence (WASI)
(Wechsler 1999), which were used to estimate general
cognitive abilities (IQ). The CVLT II scores several
parameters of episodic memory function, including a
total learning score, and free recall after 30 min. The
CWIT comprises four conditions: the naming of color
patches (1), reading of color words (2), color-word inhi-
bition (3), and color-word inhibition/switching (4), with
the third included in this study. For a more thorough
description of the NCNG sample and tests, see (Espeseth
et al. 2012).
The whole sample underwent genome-wide genotyping
using the Illumina Human610-Quad Beadchip. The
description of quality control is provided in Espeseth et al.
(2012). Imputation was performed according to the
ENIGMA protocol (Stein et al. 2012) (http://enigma.lo-
ni.ucla.edu/protocols/) with the use of MACH (Li et al.
2009, 2010) and minimac (Howie et al. 2012) imputation
software. The 1000 Genomes Project reference haplotype
dataset, Interim Phase 1 release for the European popula-
tions (EUR) was used. SNPs with an imputation quality
estimate r2 value >0.5 were considered to be successfully
imputed and the most likely genotypes were derived from
the dosage values. A postimputation quality control was
performed to exclude SNPs with a call rate <0.95, minor
allele frequency (MAF) <0.01, and Hardy–Weinberg
Equilibrium (HWE; exact test) P-value <0.001. After qual-
ity control of the NCNG genotyping data, 645 individuals
remained. The markers located in the ARC gene
(+/10 kb) or in LD were identified using the LDsnpR
tool (Christoforou et al. 2012). This set consisted of two
SNPs that were genotyped and 69 SNPs that were
imputed.
Betula
The Betula Project is a longitudinal study (est. 1988)
on aging, memory, and dementia. This sample consists
of individuals that were assessed for cognitive functions
of memory, speed of processing, and attention (Nilsson
et al. 2004;). The measures of cognitive function used
here were selected to allow comparison with the NCNG
sample (see Table 2). We used a subset of 1800 Betula
samples for which DNA was available. Samples were
genotyped for 19 markers in the ARC gene, which were
selected to ensure a complete coverage of the ARC
10 kb region and SNPs in LD. A special emphasis
was placed on rare SNPs in the region identified by
the 1000 Genomes Project (http://www.1000genome-
s.org/). Genotyping was done with a custom Illumina
iSelect array. Samples were subjected to stringent qual-
ity control in PLINK. SNPs were excluded from the
analysis if they had a failure rate <0.95, MAF <0.01, or
HWE exact test P < 0.001. After quality control of the
iSelect genotyping data, 1742 individuals remained. All
participants signed informed consent, in accordance
Table 2. Summary of the complementary cognitive tasks analyzed in
the NCNG and Betula samples.
Cognitive
aspect tested NCNG test Betula test Measure
Semantic
knowledge
Vocabulary
(WASI)
Vocabulary Word
comprehension
Visuospatial
ability
Matrix
Reasoning
(WASI)
Block design
test
Visuospatial
ability
Estimated IQ Estimated IQ
from
Vocabulary and
Matrix
Reasoning
(WASI)
Estimated from
Vocabulary and
the Block
design test
Intellectual
function
Episodic
memory
California Verbal
Learning Test-
II: Total
learning
Encoding and
free recall of
short sentences
Verbal
learning
Delayed
episodic
memory
California Verbal
Learning Test-
II: Recall
Delayed cued
recall of nouns
in sentences
Verbal recall
Processing
speed
Third condition
of CWIT from
D-KEFS
Letter-digit
substitution
Response
inhibition
WASI, Wechsler Abbreviated Scale of Intelligence; CWIT, Color-Word
Interference Test; D-KEFS, Delis–Kaplan Executive Function System.
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with the guidelines of the Swedish Council for Research
in Humanities and Social Sciences.
Analysis of NCNG and Betula samples
To test whether SNPs were associated with the different
cognitive tests selected, we performed linear regression
analyses using PLINK (Purcell et al. 2007). Age and sex
were set as covariates except for the IQ measure, which
had already been adjusted for age.
Norwegian ADHD sample
After excluding known duplicates and family members,
individuals with self-reported mental retardation and sam-
ples not meeting the quality control criteria outlined below
(143 samples), the Norwegian ADHD sample consists of
661 adult ADHD cases and 697 population controls. For
information about recruitment, phenotyping and DNA
collection, see (Johansson et al. 2008; Halmøy et al. 2009).
Tag SNPs were selected to adequately cover the ARC gene
and SNPs in LD (for detailed protocol see (Le Hellard
et al. 2009). Quality control was done using PLINK (Pur-
cell et al. 2007), and consisted of excluding individuals
with <90% call rate, as well as markers with <95% geno-
type frequency and those significantly out of Hardy–Wein-
berg equilibrium (P = 0.01). The ARC gene was tagged
using HapMap phase III data, spanning a region of
38.4 kb. The tagging region did not overlap with other
genes. A total of nine SNPs were genotyped at the CIGENE
platform at the Norwegian University of Life Sciences at
As, using the MassARRAY iPLEX system (Sequenom, San
Diego, CA). One SNP was excluded for HWE P-value
<0.001, leaving 8 SNPs for further analysis. Statistical anal-
yses were done by using single-point analysis through
logistical regression in PLINK using gender as a covariate.
Results
ARC genetic variants and cognitive abilities
Summary statistics of the NCNG cognitive tasks are dis-
played in Table 3. We extracted all of the imputed and
genotyped markers located within the ARC gene 10 kb
from the GWAS performed on the NCNG sample
(Espeseth et al. 2012). We also included all the markers
that were in LD with ARC (r2 > 0.8) using the LDsnpR
tool (Christoforou et al. 2012). Thus, all genetic variation
in ARC and correlated with ARC was included. Regions in
LD with ARC can be visualized in the LD plot of the ARC
locus (Figure S1). Linear regression analysis revealed nom-
inally significant association (P < 0.05, without multiple
testing correction) between SNPs in the 20 kb region
flanking ARC and the visuospatial ability subset, delayed
episodic memory, and episodic memory (Table 4).
Although the data were extracted from a genome wide
association study, we here calculated a less conservative
study level. We factored in the number of markers tested
(71) and their nonindependence [i.e., their linkage dise-
quilibrium (LD)], as well as the phenotype correlation.
We calculated that a correct value of study-wide signifi-
cance would be P-value <0.001 for association with cogni-
tive function. Thus, none of the associations remained
significant at the study-wide level. For a complete list of
each SNP’s P-value, see Table S1 for the NCNG sample.
Analogous cognitive tests were analyzed from a sample
of 1800 Betula participants (Table 2). Ten ARC genetic
variant markers were genotyped using an iSelect platform,
and a linear regression analysis was performed with age
and gender as covariates. No association was detected
between any ARC SNP and the cognitive functions tested.
A summary of all nominally associated SNPs in the two
samples is listed in Table 4. For a complete list of each
SNP’s P-value in the Betula sample, see Table S2.
ARC genetic variants and ADHD
In our Norwegian ADHD sample, we genotyped and
analyzed 8 tagging SNPs of ARC and the surrounding
region in a sample of 661 adult ADHD patients and 697
controls. Single-point analyses did not reveal any signifi-
cant association between ADHD and ARC genotypes. The
P-values of SNP analyses are given in Table S3.
Discussion
The study presented here indicates that common genetic
variants within ARC (10 kb) are not associated with
Table 3. Summary statistics of NCNG cognitive tasks.
Cognitive test Mean Median 95% CI
NCNG
Vocabulary (WASI) 65.5 67 0.54
Matrix Reasoning (WASI) 27.8 29 0.35
Estimated IQ from Vocabulary
and Matrix Reasoning (WASI)
118.9 120 0.80
California Verbal Learning
Test-II: Total learning
56.9 58 0.83
California Verbal Learning
Test-II: Recall
13.2 14 0.21
Third condition of CWIT
from D-KEFS
52.2 50 0.98
WASI, Wechsler Abbreviated Scale of Intelligence; CWIT, Color-Word
Interference Test; D-KEFS, Delis–Kaplan Executive Function System.
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normal variation in human cognition in our samples or
with ADHD.
We have previously shown evidence for significant
associations between variants in DCLK1 and variants in
BDNF and ARC, which affected verbal memory and gen-
eral cognitive abilities in a smaller NCNG sample (Le
Hellard et al. 2009). Here, using an extended NCNG
sample and an additional sample (the Betula) as well as
higher coverage of the ARC gene, no associations
between common genetic variants within ARC and cog-
nition were found. However, we cannot completely
exclude association between genetic variants in ARC and
cognitive abilities for several reasons. First, ARC variants
might associate with specific cognitive abilities other
than those tested here. Our analysis included word com-
prehension, visuospatial ability, intellectual function, ver-
bal learning, verbal recall, and response inhibition, but
more detailed measures qualifying as cognitive endophe-
notypes and tests for nonverbal episodic memory should
be included in further studies. Second, recent GWAS
confirm that genetic factors contribute to a large extent
to the interindividual variability in cognitive abilities
(Davies et al. 2011), but their individual effect is very
small and difficult to detect with classical GWAS (Davies
et al. 2015). The nonsignificant study-wide associations
between ARC SNPs and the traits examined here is con-
sistent with the intricate, polygenic genetic architecture
of complex traits such as cognition and psychiatric dis-
orders. It is also in line with the assumption that much
of the heritability that cannot yet be explained by
GWAS (aka the “hidden heritability”), but that is shown
to be attributable to common variants, could partially
be accounted for by many variants of very small effect
size (Visscher et al. 2012). Larger sample sizes may pro-
vide the power needed to detect these effects. Lastly,
much is still to be learned about ARC. It is exquisitely
regulated at nearly every level (epigenetically, mRNA
transport, by miRNAs, mRNA and protein degradation,
Table 4. Nominal associations of ARC SNPs with cognitive abilities (NCNG: N = 670; Betula: N = 1800.
SNP
M/m
allele MAF1
Semantic
Knowledge
P-value
[Sample]2
Visuospatial
Abilities
P-value
[Sample]2
Delayed Episodic
Memory
P-value
[Sample]2
Estimated
IQ
P-value
[Sample]2
Episodic
Memory
P-value
[Sample]2
Processing
Speed
P-value
[Sample]2
rs13273921 T/C 0.486 — — 0.045 [N] — — —
rs13260813 A/C 0.092 — — — — 0.03 [B] —
rs28625055 G/A 0.225 — 0.045 [B] 0.03 [B] — — —
rs79905110 G/A 0.095 — 0.03 [N] — — — —
rs10105842 C/T 0.134 — 0.03 [B] — — — —
rs10110456 G/A 0.088 — 0.04 [B] — — — —
—, Indicates nonsignificance.
1MAF = Minor Allele Frequency (European).
2N = NCNG; B = Betula.
Figure 1. Regulatory features of ARC gene and location of SNPs. The red region indicates the coding sequence and the blue regions are exons.
Regulatory features of ARC are indicated on the top while nominally associated ARC SNPs are indicated on the bottom. (SARE = synaptic activity-
response element; SRE = serum response element; ZLF RE = Zeste-like factor response element; A2RE = hnRNP A2 response element; hsa-miR-
19a = Homo sapiens microRNA-19a predicted binding site; DTE = dendritic targeting element).
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etc.), and other mechanisms are certainly yet to be
described. Some known regulatory regions of ARC are
shown in Fig. 1, along with the location of the nomi-
nally associated SNPs. Based on current knowledge of
ARC regulatory regions, none of the nominally signifi-
cant SNPs in this study are likely to have functional
significance. Large-scale sequencing is needed to identify
the full range of SNPs present within ARC, in ARC-
regulating regions, and other SNPs in ARC signaling
complexes.
Recent studies on the genetic etiology of SCZ have
reported de novo copy number variants (CNVs), small
de novo mutations, and rare coding variants in genes
encoding for proteins implicated in an ARC signaling
complex (Kirov et al. 2012; Fromer et al. 2014; Purcell
et al. 2014). While substantial further study is required,
these studies have pointed at the involvement of an
ARC complex in SCZ. It will thus be necessary to carry
out similar studies to characterize the implication of
rare ARC variants and in genes of ARC complexes in
cognitive functions. We also note that none of the
common ARC variants reported in the Psychiatric
Genomics Consortium database showed significant asso-
ciation with SCZ (Ripke et al. 2014).
Impairments in cognitive function are observed across
the major neuropsychiatric disorders (Gottesman and
Gould 2003; Hasler et al. 2006). We therefore utilized
our Norwegian ADHD sample to test for association
between ARC SNPs and ADHD, but found no signifi-
cant associations. Since present ADHD diagnostic cate-
gories are rather heterogeneous, more precise phenotypic
categories should be analyzed. More importantly, a more
thorough association analysis between ARC variants and
other neuropsychiatric disorders deserves consideration.
As a tightly controlled gene central to brain plasticity
and cognition, variation in ARC may still prove to
confer beneficial and/or deleterious effects on human
cognitive abilities.
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